{
    "id": 23887,
    "fullName": "ERBB2 S783P",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) S783P lies within the protein kinase domain of the Erbb2 (Her2) protein (UniProt.org). S783P is predicted to have no effect on Erbb2 (Her2) protein function, as it does not result in increased phosphorylation of Erbb2 (Her2) or downstream targets in cultured cells (PMID: 28164408), however, is associated with Tykerb (lapatinib)-resistance in cell culture (PMID: 18413839).",
            "references": [
                {
                    "id": 5983,
                    "pubMedId": 18413839,
                    "title": "EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18413839"
                },
                {
                    "id": 11367,
                    "pubMedId": 28164408,
                    "title": "HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28164408"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "S783P",
    "createDate": "06/29/2016",
    "updateDate": "10/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 170753,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39724765T>C",
        "cDna": "c.2347T>C",
        "protein": "p.S783P",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7322,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, XL647 inhibited survival of transformed cells over expressing ERBB2 (HER2) S783P in culture (PMID: 18413839).",
            "molecularProfile": {
                "id": 24612,
                "profileName": "ERBB2 S783P"
            },
            "therapy": {
                "id": 967,
                "therapyName": "XL647",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5983,
                    "pubMedId": 18413839,
                    "title": "EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18413839"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7309,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells over expressing ERBB2 (HER2) S783P were resistant to Tykerb (lapatinib) in culture (PMID: 18413839).",
            "molecularProfile": {
                "id": 24612,
                "profileName": "ERBB2 S783P"
            },
            "therapy": {
                "id": 787,
                "therapyName": "Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 5983,
                    "pubMedId": 18413839,
                    "title": "EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18413839"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24612,
            "profileName": "ERBB2 S783P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 170754,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39724765T>C",
            "cDna": "c.2347T>C",
            "protein": "p.S783P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 170753,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39724765T>C",
            "cDna": "c.2347T>C",
            "protein": "p.S783P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}